You are here

Article Text

Article menu
Download PDFPDF
Commentary
Immature neutrophils bring anti-PD-1 therapy in NASH-HCC to maturity

http://dx.doi.org/10.1136/gutjnl-2022-327396

Statistics from Altmetric.com

    Request Permissions

    如果你想任何或重用all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Correction noticeThis article has been corrected since it published Online First. A duplicated sentence has been removed.

    • ContributorsFT and MD equally contributed to the commentary for Leslieet al.

    • FundingThe authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interestsNone declared.

    • Provenance and peer reviewCommissioned; internally peer reviewed.

    Linked Articles

    • Hepatology
      CXCR2 inhibition enables NASH-HCC immunotherapy
      Jack Leslie John B G Mackey Thomas Jamieson Erik Ramon-Gil Thomas M Drake Frédéric Fercoq William Clark Kathryn Gilroy Ann Hedley Colin Nixon Saimir Luli Maja Laszczewska Roser Pinyol Roger Esteban-Fabró Catherine E Willoughby Philipp K Haber Carmen Andreu-Oller Mohammad Rahbari Chaofan Fan Dominik Pfister Shreya Raman Niall Wilson Miryam Müller Amy Collins Daniel Geh Andrew Fuller David McDonald Gillian Hulme Andrew Filby Xabier Cortes-Lavaud Noha-Ehssan Mohamed Catriona A Ford Ximena L Raffo Iraolagoitia Amanda J McFarlane Misti V McCain Rachel A Ridgway Edward W Roberts Simon T Barry Gerard J Graham Mathias Heikenwälder Helen L Reeves Josep M Llovet Leo M Carlin Thomas G Bird Owen J Sansom Derek A Mann
      Gut 2022; 71 2093-2106 Published Online First:27 Apr 2022. doi:10.1136/gutjnl-2021-326259